产品编号 |
bs-46005P |
英文名称 |
Recombinant SARS-Cov-2 Spike RBD protein, Fc-Avi (HEK293)
|
中文名称 |
重组SARS冠状病毒2 Spike RBD 蛋白 |
别 名 |
coronavirus spike Protein, 2019-nCoV; cov spike Protein, 2019-nCoV; novel coronavirus RBD Protein, 2019-nCoV; novel coronavirus s1 Protein, 2019-nCoV; novel coronavirus spike Protein, 2019-nCoV; RBD Protein, 2019-nCoV; S1 Protein, 2019-nCoV; pike RBD Prot 新冠病毒S蛋白RBD; 新冠S蛋白RBD; SARS-CoV-2 S蛋白RBD; |
理论分子量 |
51.7 kDa |
检测分子量 |
65 |
性 状 |
Lyophilized or Liquid |
浓 度 |
>0.5 mg/ml |
物 种 |
SARS-Cov-2 |
序 列 |
319-532/1273 |
纯 度 |
>95% as determined by SDS-PAGE |
纯化方法 |
AC |
内毒素 |
Not analyzed |
表达系统 |
HEK293 cell |
活性 |
Yes |
标签 |
Fc & Avi |
缓 冲 液 |
Lyophilized from 0.22um filtered solution in 2X PBS (pH7.4). Normally 5% trehalose is added as protectant before lyophilization. |
保存条件 |
Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事项 |
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
产品介绍 |
The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
|
|
|